Balance Sheet Bolt Biotherapeutics, Inc.

Stocks

BOLT

US0977022039

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 01:30:00 22/07/2026 am IST			5-day change	1st Jan Change
4.020 ^USD	-10.17%		-0.74%	-26.48%

13/05	Bolt Biotherapeutics reports first quarter 2026 financial results	RE
13/05	Bolt Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

9a9fb50bd2f2933937f83de1287b60b.PkV0AeLPGr4SbYEyRoGyqeQg0-UTOPDmzO83HajHwR8.eRANUZaeaOhXMsl7Cu7L-rcRn6N2dYSrmNZRUMuosFVKdCIwuoou2V4s6g

Published financial data: BOLT BIOTHERAPEUTICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	12.6L	57.29L	78.76L	76.9L	76.95L
Total Revenues	12.6L	57.29L	78.76L	76.9L	76.95L
Cost of Goods Sold, Total	7.57Cr	7.31Cr	6.15Cr	5.75Cr	2.85Cr
Gross Profit	-7.44Cr	-6.74Cr	-5.37Cr	-4.98Cr	-2.08Cr
Selling General & Admin Expenses, Total	1.84Cr	2.29Cr	2.25Cr	1.85Cr	1.38Cr
Other Operating Expenses, Total	1.84Cr	2.29Cr	2.25Cr	1.85Cr	1.38Cr
Operating Income	-9.28Cr	-9.03Cr	-7.62Cr	-6.82Cr	-3.46Cr
Interest And Investment Income	3L	22.23L	69.99L	52.55L	24.96L
Net Interest Expenses	3L	22.23L	69.99L	52.55L	24.96L
Other Non Operating Income (Expenses)	-60.84L	-	-	-	2L
EBT, Excl. Unusual Items	-9.86Cr	-8.81Cr	-6.92Cr	-6.3Cr	-3.19Cr
Restructuring Charges	-	-	-	-33.43L	-14.8L
Asset Writedown	-	-	-	-14.69L	-
Other Unusual Items	-	-	-	46.75L	-
EBT, Incl. Unusual Items	-9.86Cr	-8.81Cr	-6.92Cr	-6.31Cr	-3.34Cr
Earnings From Continuing Operations	-9.86Cr	-8.81Cr	-6.92Cr	-6.31Cr	-3.34Cr
Net Income to Company	-9.86Cr	-8.81Cr	-6.92Cr	-6.31Cr	-3.34Cr
Net Income - (IS)	-9.86Cr	-8.81Cr	-6.92Cr	-6.31Cr	-3.34Cr
Net Income to Common Incl Extra Items	-9.86Cr	-8.81Cr	-6.92Cr	-6.31Cr	-3.34Cr
Net Income to Common Excl. Extra Items	-9.86Cr	-8.81Cr	-6.92Cr	-6.31Cr	-3.34Cr
Per Share Items
Net EPS - Basic	-59.4	-47.16	-36.6	-33.06	-17.85
Basic EPS - Continuing Operations	-59.4	-47.16	-36.6	-33.06	-17.85
Basic Weighted Average Shares Outstanding	16.6L	18.68L	18.91L	19.09L	18.7L
Net EPS - Diluted	-59.4	-47.16	-36.6	-33.06	-17.85
Diluted EPS - Continuing Operations	-59.4	-47.16	-36.6	-33.06	-17.85
Diluted Weighted Average Shares Outstanding	16.6L	18.68L	18.91L	19.09L	18.7L
Normalized Basic EPS	-37.12	-29.48	-22.88	-20.62	-10.66
Normalized Diluted EPS	-37.12	-29.48	-22.88	-20.62	-10.66
Supplemental Items
EBITDA	-9.16Cr	-8.87Cr	-7.43Cr	-6.65Cr	-3.33Cr
EBITA	-9.28Cr	-9.03Cr	-7.62Cr	-6.82Cr	-3.46Cr
EBIT	-9.28Cr	-9.03Cr	-7.62Cr	-6.82Cr	-3.46Cr
EBITDAR	-8.86Cr	-8.51Cr	-7.07Cr	-6.23Cr	-3.07Cr
Normalized Net Income	-6.16Cr	-5.51Cr	-4.32Cr	-3.94Cr	-1.99Cr
Interest on Long-Term Debt	-	-	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	1.84Cr	2.29Cr	2.25Cr	1.85Cr	1.38Cr
Research And Development Expense From Footnotes	7.57Cr	7.31Cr	6.15Cr	5.75Cr	2.85Cr
Net Rental Expense, Total	30.42L	35.46L	36.8L	41.22L	26.05L
Stock-Based Comp., COGS (Total)	44.6L	41.09L	37.02L	31.52L	11.62L
Stock-Based Comp., G&A Exp. (Total)	40.4L	54.67L	55.21L	42.55L	16.2L
Total Stock-Based Compensation	85L	95.76L	92.23L	74.07L	27.82L

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.74Cr	92.44L	1.08Cr	72.05L	1.17Cr
Short Term Investments	16Cr	16Cr	9.14Cr	4.01Cr	1.58Cr
Total Cash And Short Term Investments	19Cr	17Cr	10Cr	4.73Cr	2.75Cr
Other Receivables	2L	8L	13L	8L	10L
Total Receivables	2L	8L	13L	8L	10L
Prepaid Expenses	27.41L	30.58L	20.41L	18.44L	14.07L
Restricted Cash	-	-	-	8L	2L
Other Current Assets, Total	-	-	2L	55T	2L
Total Current Assets	19Cr	17Cr	11Cr	5.08Cr	3.03Cr
Gross Property Plant And Equipment	3.28Cr	3.24Cr	2.98Cr	3.22Cr	2.79Cr
Accumulated Depreciation	-22.45L	-39.15L	-57.52L	-72.78L	-73.87L
Net Property Plant And Equipment	3.06Cr	2.85Cr	2.41Cr	2.49Cr	2.05Cr
Long-term Investments	8.53Cr	2.39Cr	2.64Cr	2.29Cr	43.37L
Deferred Charges Long-Term	-	-	4L	51T	1L
Other Long-Term Assets, Total	26.07L	25.93L	32.15L	10L	15.39L
Total Assets	31Cr	23Cr	16Cr	9.96Cr	5.67Cr
Liabilities
Accounts Payable, Total	35.74L	35.94L	29.87L	15.07L	14.43L
Accrued Expenses, Total	1.24Cr	1.51Cr	1.25Cr	83.44L	29.73L
Current Portion of Leases	25.01L	23.91L	27.82L	22.51L	28.26L
Unearned Revenue Current, Total	28.69L	19.93L	22.01L	30.15L	4L
Other Current Liabilities	-	-	-	7L	7L
Total Current Liabilities	2.13Cr	2.31Cr	2.05Cr	1.59Cr	84.35L
Long-Term Leases	2.19Cr	2.02Cr	1.74Cr	2.3Cr	2.01Cr
Unearned Revenue Non Current	1.42Cr	1.29Cr	91.07L	36.2L	15.44L
Other Non Current Liabilities	2L	42T	43T	-	1L
Total Liabilities	5.76Cr	5.63Cr	4.7Cr	4.24Cr	3.02Cr
Preferred Stock Convertible	-	-	-	-	-
Preferred Stock - Others	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	-	-	1T	-	-
Additional Paid In Capital	46Cr	47Cr	48Cr	48Cr	49Cr
Retained Earnings	-21Cr	-30Cr	-36Cr	-43Cr	-46Cr
Comprehensive Income and Other	-3L	-9L	37T	97T	-21T
Total Common Equity	25Cr	17Cr	11Cr	5.72Cr	2.65Cr
Total Equity	25Cr	17Cr	11Cr	5.72Cr	2.65Cr
Total Liabilities And Equity	31Cr	23Cr	16Cr	9.96Cr	5.67Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	18.73L	18.91L	19.06L	19.17L	19.22L
ECS Total Common Shares Outstanding	18.7L	18.9L	19.06L	19.17L	19.21L
Book Value / Share	133.75	90.75	59.16	29.84	13.8
Tangible Book Value	25Cr	17Cr	11Cr	5.72Cr	2.65Cr
Tangible Book Value Per Share	133.75	90.75	59.16	29.84	13.8
Total Debt	2.44Cr	2.26Cr	2.02Cr	2.52Cr	2.3Cr
Net Debt	-16Cr	-15Cr	-8.2Cr	-2.21Cr	-45.47L
Debt Equivalent Oper. Leases	2.43Cr	2.84Cr	2.94Cr	3.3Cr	2.08Cr
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	82.58L	1.01Cr	1.04Cr	1.01Cr	82.74L
Full Time Employees	91	94	100	52	23

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-9.86Cr	-8.81Cr	-6.92Cr	-6.31Cr	-3.34Cr
Depreciation & Amortization - CF	11.93L	16.66L	18.54L	17.81L	12.91L
Depreciation & Amortization, Total	11.93L	16.66L	18.54L	17.81L	12.91L
(Gain) Loss From Sale Of Asset	1L	-	-	-70T	-3L
(Gain) Loss on Sale of Investments - (CF)	26.54L	2L	-44.93L	-26.15L	-7L
Asset Writedown & Restructuring Costs	-	-	-	14.69L	-
Stock-Based Compensation (CF)	85L	95.76L	92.23L	74.07L	27.82L
Other Operating Activities, Total	85.63L	32.25L	29.52L	22.97L	25.26L
Change In Accounts Payable	66.76L	27.68L	-34.13L	-48.83L	-54.3L
Change in Unearned Revenues	1.56Cr	-21.62L	-36.06L	-46.73L	-46.42L
Change in Other Net Operating Assets	-17.43L	-36.63L	-28.45L	11.16L	-20.43L
Cash from Operations	-5.71Cr	-7.65Cr	-6.95Cr	-6.13Cr	-3.98Cr
Capital Expenditure	-23.38L	-19.53L	-2L	-41T	-72T
Sale of Property, Plant, and Equipment	-	-	-	1L	10L
Investment in Marketable and Equity Securities, Total	-23Cr	5.98Cr	7.12Cr	5.75Cr	4.34Cr
Cash from Investing	-23Cr	5.79Cr	7.1Cr	5.76Cr	4.43Cr
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Issuance of Common Stock	26Cr	5L	3L	1L	19T
Issuance of Preferred Stock	5.19Cr	-	-	-	-
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	31Cr	5L	3L	1L	19T
Net Change in Cash	2.18Cr	-1.81Cr	17.66L	-36.05L	44.71L
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Levered Free Cash Flow	-4.2Cr	-4.62Cr	-3.95Cr	-3.75Cr	-2.49Cr
Unlevered Free Cash Flow	-4.2Cr	-4.62Cr	-3.95Cr	-3.75Cr	-2.49Cr
Change In Net Working Capital	-86.46L	-10L	27.14L	40.41L	72.6L
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-32.74	-21.08	-24.57	-32.88	-27.68
Return on Total Capital	-37.3	-24.09	-29.12	-39.6	-32.83
Return On Equity %	-71.52	-41.79	-48.69	-74.28	-79.75
Return on Common Equity	-135.83	-41.79	-48.69	-74.28	-79.75
Margin Analysis
Gross Profit Margin %	-5.9T	-1.18T	-681.39	-647.32	-270.8
SG&A Margin	1.46T	400.19	286.06	240.01	179.27
EBITDA Margin %	-7.27T	-1.55T	-943.91	-864.17	-433.29
EBITA Margin %	-7.36T	-1.58T	-967.45	-887.33	-450.07
EBIT Margin %	-7.36T	-1.58T	-967.45	-887.33	-450.07
Income From Continuing Operations Margin %	-7.82T	-1.54T	-878.58	-820.78	-433.74
Net Income Margin %	-7.82T	-1.54T	-878.58	-820.78	-433.74
Net Avail. For Common Margin %	-7.82T	-1.54T	-878.58	-820.78	-433.74
Normalized Net Income Margin	-4.89T	-961.1	-549.11	-511.87	-259.06
Levered Free Cash Flow Margin	-3.33T	-806.05	-501.09	-488.19	-323.65
Unlevered Free Cash Flow Margin	-3.33T	-806.05	-501.09	-488.19	-323.65
Asset Turnover
Asset Turnover	0.01	0.02	0.04	0.06	0.1
Fixed Assets Turnover	0.05	0.19	0.3	0.31	0.34
Short Term Liquidity
Current Ratio	8.87	7.47	5.17	3.2	3.59
Quick Ratio	8.74	7.34	5.06	3.04	3.38
Operating Cash Flow to Current Liabilities	-2.68	-3.31	-3.4	-3.87	-4.72
Average Days Payable Outstanding	12.48	17.89	19.52	14.31	18.87
Long Term Solvency
Total Debt/Equity	9.74	13.18	17.93	44.07	86.62
Total Debt / Total Capital	8.87	11.65	15.21	30.59	46.41
LT Debt/Equity	8.74	11.79	15.47	40.14	75.96
Long-Term Debt / Total Capital	7.96	10.42	13.11	27.86	40.7
Total Liabilities / Total Assets	18.72	24.71	29.44	42.59	53.29
Total Debt / EBITDA	-0.28	-0.27	-0.29	-0.4	-0.75
Net Debt / EBITDA	1.83	1.72	1.16	0.35	0.15
Total Debt / (EBITDA - Capex)	-0.27	-0.26	-0.29	-0.4	-0.75
Net Debt / (EBITDA - Capex)	1.78	1.68	1.16	0.35	0.15
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	445.45	354.68	37.48	-2.36	0.06
Gross Profit, 1 Yr. Growth %	85.4	-9.41	-20.37	-7.24	-58.14
EBITDA, 1 Yr. Growth %	88.58	-3.21	-16.14	-10.61	-49.83
EBITA, 1 Yr. Growth %	88.66	-2.66	-15.64	-10.45	-49.25
EBIT, 1 Yr. Growth %	88.66	-2.66	-15.64	-10.45	-49.25
Earnings From Cont. Operations, 1 Yr. Growth %	62.35	-10.64	-21.45	-8.79	-47.12
Net Income, 1 Yr. Growth %	62.35	-10.64	-21.45	-8.79	-47.12
Normalized Net Income, 1 Yr. Growth %	62.35	-10.64	-21.45	-8.98	-49.36
Diluted EPS Before Extra, 1 Yr. Growth %	-89.72	-20.6	-22.4	-9.67	-46.01
Net Property, Plant and Equip., 1 Yr. Growth %	87.17	-6.79	-15.59	3.4	-17.75
Total Assets, 1 Yr. Growth %	561.16	-25.97	-29.86	-37.65	-43.04
Tangible Book Value, 1 Yr. Growth %	-338.33	-31.43	-34.26	-49.27	-53.66
Common Equity, 1 Yr. Growth %	-338.33	-31.43	-34.26	-49.27	-53.66
Cash From Operations, 1 Yr. Growth %	20.63	34.06	-9.12	-11.85	-34.98
Capital Expenditures, 1 Yr. Growth %	-28.33	-16.47	-89.45	-80.1	75.61
Levered Free Cash Flow, 1 Yr. Growth %	43.73	9.97	-14.54	-4.88	-33.66
Unlevered Free Cash Flow, 1 Yr. Growth %	43.73	9.97	-14.54	-4.88	-33.66
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	142.08	398	150.02	15.86	-1.16
Gross Profit, 2 Yr. CAGR %	69.85	29.6	-15.07	-14.06	-37.69
EBITDA, 2 Yr. CAGR %	72.92	35.1	-9.91	-13.42	-33.03
EBITA, 2 Yr. CAGR %	73.09	35.52	-9.38	-13.08	-32.58
EBIT, 2 Yr. CAGR %	73.09	35.52	-9.38	-13.08	-32.58
Earnings From Cont. Operations, 2 Yr. CAGR %	79.83	20.44	-16.22	-15.36	-30.55
Net Income, 2 Yr. CAGR %	79.83	20.44	-16.22	-15.36	-30.55
Normalized Net Income, 2 Yr. CAGR %	79.83	20.44	-16.22	-15.45	-32.11
Diluted EPS Before Extra, 2 Yr. CAGR %	-55.93	-71.43	-21.5	-16.28	-30.17
Net Property, Plant and Equip., 2 Yr. CAGR %	63.01	32.09	-11.3	-6.58	-7.78
Total Assets, 2 Yr. CAGR %	152.02	121.24	-27.94	-33.87	-40.41
Tangible Book Value, 2 Yr. CAGR %	133.57	27.84	-32.86	-42.25	-51.51
Common Equity, 2 Yr. CAGR %	133.57	27.84	-32.86	-42.25	-51.51
Cash From Operations, 2 Yr. CAGR %	47.18	27.17	10.38	-10.49	-24.29
Capital Expenditures, 2 Yr. CAGR %	114.53	-22.62	-70.32	-85.51	-40.88
Levered Free Cash Flow, 2 Yr. CAGR %	63.08	25.72	-3.05	-9.84	-20.56
Unlevered Free Cash Flow, 2 Yr. CAGR %	63.08	25.72	-3.05	-9.84	-20.56
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	198.68	224.26	82.75	10.33
Gross Profit, 3 Yr. CAGR %	99.14	37.74	10.18	-12.54	-32.38
EBITDA, 3 Yr. CAGR %	100.72	42.51	15.24	-10.14	-27.82
EBITA, 3 Yr. CAGR %	99.82	42.87	15.71	-9.74	-27.35
EBIT, 3 Yr. CAGR %	99.82	42.87	15.71	-9.74	-27.35
Earnings From Cont. Operations, 3 Yr. CAGR %	104.14	42.44	4.45	-13.81	-27.64
Net Income, 3 Yr. CAGR %	104.14	42.44	4.45	-13.81	-27.64
Normalized Net Income, 3 Yr. CAGR %	104.14	42.44	4.45	-13.88	-28.73
Diluted EPS Before Extra, 3 Yr. CAGR %	-24.93	-46.38	-60.14	-17.74	-27.67
Net Property, Plant and Equip., 3 Yr. CAGR %	176.86	35.3	13.77	-6.65	-10.46
Total Assets, 3 Yr. CAGR %	168.06	67.53	50.86	-31.33	-37.08
Tangible Book Value, 3 Yr. CAGR %	150.34	55.24	2.42	-38.85	-46.34
Common Equity, 3 Yr. CAGR %	150.34	55.24	2.42	-38.85	-46.34
Cash From Operations, 3 Yr. CAGR %	79.47	42.67	13.69	2.41	-19.54
Capital Expenditures, 3 Yr. CAGR %	100.52	56.66	-60.18	-74.02	-66.72
Levered Free Cash Flow, 3 Yr. CAGR %	-	43.01	10.54	-3.67	-18.6
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	43.01	10.54	-3.67	-18.6
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	104.5	101.61
Gross Profit, 5 Yr. CAGR %	-	-	41.62	14.06	-12.28
EBITDA, 5 Yr. CAGR %	-	-	45.69	16.75	-7.25
EBITA, 5 Yr. CAGR %	-	-	45.64	17.12	-6.77
EBIT, 5 Yr. CAGR %	-	-	45.64	17.12	-6.77
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	42.96	15.67	-11.28
Net Income, 5 Yr. CAGR %	-	-	42.96	15.67	-11.28
Normalized Net Income, 5 Yr. CAGR %	-	-	42.96	15.62	-12.08
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-23.58	-35.92	-50.11
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	75.6	16.67	4.6
Total Assets, 5 Yr. CAGR %	-	-	58.5	15.51	4.04
Tangible Book Value, 5 Yr. CAGR %	-	-	47.88	4.52	-24.06
Common Equity, 5 Yr. CAGR %	-	-	47.88	4.52	-24.06
Cash From Operations, 5 Yr. CAGR %	-	-	47.76	18.4	-3.37
Capital Expenditures, 5 Yr. CAGR %	-	-	-6.61	-39.55	-53.36
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	18.91	-3.14
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	18.91	-3.14